Frequency of CD39+, LAG3+, and CTLA4+ Regulatory T Cells in Two Different Immunosuppressive Protocols in Renal Allograft Recipients (Sirolimus vs Mycophenolate mofetil): A Cohort Report
CONCLUSIONS: it seems that both treatment regimen protocols with a low dose ATG induction therapy may be clinically applicable in kidney transplant recipients.PMID:36190377 | DOI:10.22034/iji.2022.92623.2161
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Authors: Yaghoub Mollaei-Kandelous Pedram Ahmadpoor Mohsen Nafar Mohammad Reza Khatami Samad Farashi Bonab Nader Tajik Mahdi Shekarabi Aliakbar Amirzargar Source Type: research
More News: Allergy & Immunology | Bone Graft | Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Iran Health | Kidney Transplant | Kidney Transplantation | Middle East Health | Prednisolone | Prograf | Study | Tacrolimus | Tajikistan Health | Transplant Surgery | Transplants | Urology & Nephrology